Double_Bagger said:

---

FJ43 said:

---

How did we do today?

Partial day today of trading for me. Had to pick up Mrs FJ from the airport mid afternoon.

SPY puts to open carried over from Friday close.
2 trips on SONO and left net free runners overnight.
Qs long at the bottom support and trail stopped a little before close.

Should have dumped VIX calls but didn't. Error on my part.

---

Took the risk buying the dip this morning, so it was a great day. Really appreciate the intraday commentary on this board. I almost always check the sentiment on this board before entering or exiting a position. Was able to play today to near perfection:

Carried SPY and QQQ shorts over from last week. Covered both when SPY bounced off 443
Sold half the 9/17 VIX calls at the same time.

Then went long
AAPL C150 +340%
GOOGL C2750/2760 spread +300%
MRNA C390/400 spread +160%

Hit my weekly goal so I closed all of my trades. Decided to short sell SPY and QQQ at close after seeing the S&P hit another ATH. Planning to keep trading light the rest of the week because I had similar returns last Monday and gave it all back Tuesday/Wednesday.

---

Great job congrats! Smart to play light and nimble IMO.

what made you take those trades by the way? They were good calls.

Big move coming soon.

📢 $SPY VERY LARGE Unusual #darkpool activity coming in late after-hours!

Over 16 MILLION shares at $445.86 with $2 BILLION+ money flow.

Let's take a deeper look here 🕵️‍♀️🔍👇https://t.co/VU8gC7KjS3

— MelStone Dark Pool (@MelStone31) August 16, 2021

Double_Bagger said:

---

Aggie Pharmer said:

---

I went ahead bought a few hundred shares in SESN. From what they have released from the CRL, it's hard to have a feeling of what issues FDA may have with the data. They only said that there was the request by FDA to redo the statistical analysis and provide more data.

For the CMC/quality, they should have received fairly clear guidance from FDA on how to address them; however, not knowing the nature of the issues cited it's hard to say how big the problems were that they need to address. I work in small molecules, not biologics, so there could be bigger things that I'm just not familiar with. As I had mentioned earlier, a robust PAI prep should have identified these gaps.

I quickly googled SESN dd (for due diligence) and came upon a few reddit threads where folks have laid everything out. I figured a few hundred shares at the current price was reasonable to gamble on.

Overall looking at the technology they are using, I think it's pretty interesting and hope they are able to address all of FDA's comments and get an approval.

---

Thank you for doing this research and providing your opinion on the CRL. Very much appreciated

---

Taken from the BioPharmCatalyst Daily Update email:

Sesen Bio (NASDAQ: SESN) shares fell a further 42% to $1.22 adding to Friday's fall of 57%. The company announced Friday that it received a Complete Response Letter (CRL) from the FDA regarding its Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). The FDA noted clinical/statistical data and analyses in addition to Chemistry, Manufacturing and Controls (CMC) issues following a recent pre-approval inspection and product quality for the CRL. However, in an analyst call Monday Sesen mentioned that a further 12-month confirmatory trial is required which will push out its resubmission of the BLA to 2023 at the earliest.

$30,000 Millionaire said:

---

I kept PYPL and AMD calls over night. I hope it's a good decision.

---

I did too. I will squeeze with you, Ag.

Skilled doesnt always create results.

FJ43 said:

---

How did we do today?

Partial day today of trading for me. Had to pick up Mrs FJ from the airport mid afternoon.

SPY puts to open carried over from Friday close.
2 trips on SONO and left net free runners overnight.
Qs long at the bottom support and trail stopped a little before close.

Should have dumped VIX calls but didn't. Error on my part.

---

Went into a meeting up big on spy puts, but down really big overall. Meeting lasted forever and when I came out, I was down modestly on the spy puts and had recovered to only a small loss overall. Not the trade I wanted, but not a bad trade-off.

Double_Bagger said:

---

$30,000 Millionaire said:

---

what made you take those trades by the way? They were good calls.

---

All have been on my watchlist for a long time, so I feel like I understand their movement. Also I subscribe to Unusual Whales and follow order flow on that site.

AAPL - started off the morning strong and broke 150 before pulling back with the rest of the market. Seeing it break 150 gave me confidence it could have a larger breakout if the market bounced back.
GOOGL - has been strong the last 2 weeks. I thought it was going to breakout last week and bought calls but I was early and got burned, so when it dipped this morning I took a chance. I didn't have a lot of confidence in this one since I just got burned last week, which is why I did the spread.
MRNA - This one had a lot of activity last week and hit an ATH. I thought there might be some extra dip buyers which would give it a quick recovery. Call spread because I wasn't confident and wanted a lower risk entry if it didn't bounce.

I waited until the market started to recover before entering these so I didn't get in at the bottom and also sold all before the top.

I'm not as skilled or technical as many people on this board.

---

your post and results indicate otherwise brah! well done!

Prognightmare said:

---

BREwmaster said:

---

WISH thoughts? if it was a bargain last week in the high 7's, how about the high 6's? thinking about adding some as a long long term hold.
added a bunch of CLOV today. finally back in that one. to the moon!

---

IMO, it's at a bottom. It may drop lower but I don't see much more risk in it at this price. I'm in at $6.80 and as we approach the Christmas season, it has more potential than pain in my book.

---

May be doing this similar to a way you posted accumulation on some other stocks (felt like you posted your strategy months ago on WWR or another MA stock). Selling a few puts, buying a few common, and selling calls on about half the commons. I at least like the fact the options have more intervals than some many of the other stocks in this price point range.

Added to my CLOV position as well

Double_Bagger said:

---

Double_Bagger said:

---

Aggie Pharmer said:

---

I went ahead bought a few hundred shares in SESN. From what they have released from the CRL, it's hard to have a feeling of what issues FDA may have with the data. They only said that there was the request by FDA to redo the statistical analysis and provide more data.

For the CMC/quality, they should have received fairly clear guidance from FDA on how to address them; however, not knowing the nature of the issues cited it's hard to say how big the problems were that they need to address. I work in small molecules, not biologics, so there could be bigger things that I'm just not familiar with. As I had mentioned earlier, a robust PAI prep should have identified these gaps.

I quickly googled SESN dd (for due diligence) and came upon a few reddit threads where folks have laid everything out. I figured a few hundred shares at the current price was reasonable to gamble on.

Overall looking at the technology they are using, I think it's pretty interesting and hope they are able to address all of FDA's comments and get an approval.

---

Thank you for doing this research and providing your opinion on the CRL. Very much appreciated

---

Taken from the BioPharmCatalyst Daily Update email:

Sesen Bio (NASDAQ: SESN) shares fell a further 42% to $1.22 adding to Friday's fall of 57%. The company announced Friday that it received a Complete Response Letter (CRL) from the FDA regarding its Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). The FDA noted clinical/statistical data and analyses in addition to Chemistry, Manufacturing and Controls (CMC) issues following a recent pre-approval inspection and product quality for the CRL. However, in an analyst call Monday Sesen mentioned that a further 12-month confirmatory trial is required which will push out its resubmission of the BLA to 2023 at the earliest.

---

Thanks for digging this up! I've been so busy today I haven't had time to look it up.

Price action and RSI- so I have been trying to study more price action movement and ties to divergence through RSI on multiple time frames to look for reversals in a trend. I don't have the charting expertise of many on this board, but my understanding is the lower the second peak on 8/13 with a red close should have put TSLA on watch at the open today. The News didn't help TSLA either way, but I was posting this to see how many look at RSI. It's been interesting to watch this on daily timeframes and try to spot it on lower timeframe frame to catch an options scalp but still doing that on a very small scale.

TSLA isn't the best example but it was fresh in my head from today

LOYAL AG said:

---

wanderer said:

---

wanderer said:

---

Prognightmare said:

---

This market today was so boring. To borrow a saying from my late Dad, " this is like watching two old people ****".

---

Hah. I wish my day was more boring. Thanks to WWR, PAVM, MGNI, SNDL, MVIS, NIO, XL (and others) I took a kick to the nads.

---

Different week, but same story today (can add BIGC & MBIO, UWMC to that list). Really starting to think my account needs a refresh.

---

This is when you step back and evaluate each trade and why you're in it. For example WWR should be a Q4 or Q1-22 play so anything that happens between now and then is largely irrelevant. This isn't one to watch day to day unless you just like getting kicked in the nads and, hey, some guys are into that kind of thing. Hell the practice was featured prominently in the documentary Idiocracy. But assuming you're not then don't worry about that one right now. Do the same for the rest of the trades and go from there. If you're in them for a short term swing and it's losing then evaluate the decision you're making today to stay in.

---

Point taken, thanks for the words.

It sure feels like the movement away from smallcap/growth is MM/HF's way of taking it to the new retail investors that have flooded in over the past 1.5yr. These type of investors (I'm obviously not excluded) are drawn to the growth funds and they continue to get beaten down over the past 3-4 months. This is all happening with SPY/QQQ at ATHs. What I'm fearful of is that when the overall market tanks the growth/smallcaps get hit even further. It's getting kicked on the way up and on the way down.

Active aggressive investor looking for fast portfolio growth is not Holding $WMT $HD $AAPL $AMZN , he or she invests in aggressive growth/high potential Growth Companies in next quarters that is Biotech/Midcaps/$IWM stocks etc , so reason why many portfolios red with $SPY ATH https://t.co/8Ks2dLkfdT

— Ripster (@ripster47) August 17, 2021

ELOX hitting all time lows & the charts shows no support. Looks like this will be below a $1 in no time. With P2 readings not until 4Q, don't know how we get off the steep decline.

Chinese bots are getting better. We don't say, think, or write "a one dollar" in English. Otherwise it seems pretty close for message board chatter.

Covid booster play: FDX primary shipper of vaxx

wanderer said:

---

LOYAL AG said:

---

wanderer said:

---

wanderer said:

---

Prognightmare said:

---

This market today was so boring. To borrow a saying from my late Dad, " this is like watching two old people ****".

---

Hah. I wish my day was more boring. Thanks to WWR, PAVM, MGNI, SNDL, MVIS, NIO, XL (and others) I took a kick to the nads.

---

Different week, but same story today (can add BIGC & MBIO, UWMC to that list). Really starting to think my account needs a refresh.

---

This is when you step back and evaluate each trade and why you're in it. For example WWR should be a Q4 or Q1-22 play so anything that happens between now and then is largely irrelevant. This isn't one to watch day to day unless you just like getting kicked in the nads and, hey, some guys are into that kind of thing. Hell the practice was featured prominently in the documentary Idiocracy. But assuming you're not then don't worry about that one right now. Do the same for the rest of the trades and go from there. If you're in them for a short term swing and it's losing then evaluate the decision you're making today to stay in.

---

Point taken, thanks for the words.

It sure feels like the movement away from smallcap/growth is MM/HF's way of taking it to the new retail investors that have flooded in over the past 1.5yr. These type of investors (I'm obviously not excluded) are drawn to the growth funds and they continue to get beaten down over the past 3-4 months. This is all happening with SPY/QQQ at ATHs. What I'm fearful of is that when the overall market tanks the growth/smallcaps get hit even further. It's getting kicked on the way up and on the way down.

Active aggressive investor looking for fast portfolio growth is not Holding $WMT $HD $AAPL $AMZN , he or she invests in aggressive growth/high potential Growth Companies in next quarters that is Biotech/Midcaps/$IWM stocks etc , so reason why many portfolios red with $SPY ATH https://t.co/8Ks2dLkfdT

— Ripster (@ripster47) August 17, 2021

---

When I first started trading at the beginning of 2012 AAPL had just rolled out the 4S and by all accounts three were set to announce a blowout prior quarter in their Jan 12 earnings. We heard from several of their suppliers that they'd had record quarters themselves due largely to an unnamed huge customer and sure enough they reported incredible results and completely took over the market for the next several weeks or more.

It was so absurd that I remember people referring to the NASDAAPL and we were in an extended period where AAPL was seemingly the only stock that was going up and it pulled the indices with it even as a significant portion of the broader markets were flat or negative. These things happen where we see positive movement overall but it's due to a short list of blue chips. It's one of those periods where the market can stay irrational longer than you can stay liquid. I'm guessing you're right about small caps when we do see a pullback in the coming weeks but from my list I really only have one or two I'd like to cut before that happens and I'll probably do that this week even as both will book loses. Trade what's in front of you, that's the key.

Prediction: PROG will bottom between $1.05 and $1.15.